Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2466351012 | Hydrocodone polistirex 10mg/chlorpheniremine polistirex 8mg per 5mL oral m/r suspension (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2472547012 | Hydrocodone polistirex 10mg/chlorpheniremine polistirex 8mg per 5mL oral m/r suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2536765011 | Hydrocodone polistirex 10mg/chlorpheniremine polistirex 8mg per 5mL oral extended release suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2859901000052118 | hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Is a | hydrokodonpolistirex + klorfeniraminpolistirex | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Has active ingredient | Chlorphenamine | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Has active ingredient | Hydrocodone (substance) | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Has manufactured dose form | Oral suspension | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Is a | Chlorphenamine-containing product in oral dose form | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Has active ingredient | Chlorphenamine polistirex (substance) | false | Inferred relationship | Some | ||
hydrokodonpolistirex 10 mg/5 ml + klorfeniraminpolistirex 8 mg/5 ml, oral suspension med modifierad frisättning | Has active ingredient | Hydrocodone polistirex (substance) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set